News

Visit GlycoMark’s Booth at AADE 2018


Posted on July 6, 2018 by


Visit booth #748 at AADE18 organized by the American Association of Diabetes Educators in Baltimore, MD on August 17-20, 2018, to learn more about the GlycoMark test. This test is the only FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic excursions (occurring in the fasting state, postprandial, or both).  To schedule a meeting…
Read More

Meet with GlycoMark at AACC 2018!


Posted on July 6, 2018 by


Are you attending the American Association of Clinical Chemistry (AACC) 70th Annual Scientific Meeting & Clinical Lab Expo in August? While in Chicago, meet with GlycoMark’s management team to learn more about the GlycoMark test – the only FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic excursions (occurring in the fasting state, postprandial,…
Read More

GlycoMark®, Inc. Partners with Sheil Medical Laboratory to Expand GlycoMark Test in the Northeast


Posted on April 11, 2017 by


Agreement Facilitates Greater Accessibility for Patients and Clinicians to Important Diabetes Test New York, NY (April 11, 2017) – GlycoMark, Inc. announced today a partnership with Shiel Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast U.S. GlycoMark is the only clinically available blood test that specifically indicates recent hyperglycemia in patients…
Read More

Using the HbA1c Test Wisely in Clinical Practice


Posted on October 23, 2015 by


Upcoming webinar by the American Association for Clinical Chemistry (AACC) warns of variants and adducts that may affect accuracy of A1c tests   New York, NY (October 23, 2015) – An upcoming webinar hosted by the AACC will discuss potential pitfalls of the hemoglobin A1c test due to conditional interferences that can affect the accuracy…
Read More

New Publication Featuring GlycoMark® Test Highlights Association of Hyperglycemic Excursions with Cardiovascular Outcomes and Mortality


Posted on October 23, 2015 by


NEW YORK, NY  (October 23, 2015) – In a new study published by the medical journal Diabetes involving more than 11,000 subjects, the GlycoMark test was used to help define links between hyperglycemic excursions and increased incidence of cardiovascular disease and death1. The recently published study involved analysis from the Atherosclerosis Risk In Communities (ARIC)…
Read More

GlycoMark, Inc. Announces the GlycoMark® Test is Available Through a Nationwide Partnership with Bio Reference Laboratories


Posted on October 17, 2015 by


Agreement Facilitates Greater Accessibility For Patients and Clinicians of Important Diabetes Test   New York, NY (October 17, 2015) – Glycomark, Inc., the United States commercialization channel for the Glycomark test, announced today that their assay for diabetes will be marketed nationwide through a partnership with BioReference Laboratories. The Glycomark® test is a clinically proven,…
Read More